150.01 0.00 (0.00%)
After hours: 4:45PM EDT
|Bid||149.61 x 800|
|Ask||153.99 x 800|
|Day's Range||149.01 - 152.40|
|52 Week Range||141.95 - 226.61|
|Beta (3Y Monthly)||0.97|
|PE Ratio (TTM)||13.82|
|Forward Dividend & Yield||0.04 (0.03%)|
|1y Target Est||N/A|
When Cigna closed its $54 billion deal in December to buy Express Scripts, it created one of the biggest providers of pharmacy benefits and insurance plans in the United States. Its purpose: to contain costs for employers and to leverage data to create more integrated care for consumers. We ask, how is it going so far? CNBC's Bertha Coombs leads a conversation is David Cordani, president and CEO of Cigna, alongside Tim Wentworth, president of Express Scripts and Cigna Services and former CEO of Express Scripts.
On May 21, CNBC's Healthy Returns returned for its second year, featuring interviews, panel discussions and presentations from some of the most influential leaders in health care. Speakers included United Therapeutics CEO Martine Rothblatt, Former FDA Commissioner Scott Gottlieb, Novartis CEO Vasant Narasimhan, Cigna CEO David Cordani, Johnson & Johnson CEO Alex Gorsky. A diverse set of innovative companies were represented, including Verily, Fitbit, Synthego, Kaiser Permanente, insito, Bright Health, Microsoft Health, Livongo and more.
Cigna Corp NYSE:CIView full report here! Summary * Perception of the company's creditworthiness is neutral * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CI with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CI. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding CI totaled $10.89 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swap | NeutralThe current level displays a neutral indicator. CI credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Reports indicate a pair of hedge funds believe Centene can do better than its proposed $17.3B deal for WellCare if it were to find a buyer for itself.
One of the largest healthcare networks in the region is set to end its relationship with Cigna June 14, if new contract terms aren't reached.
The St. Louis-based pharmacy benefits manager is building a digital health formulary to help guide insurers to the most effective digital health tools for their members
Clayco has named James Havel as executive vice president and CFO, effective Wednesday, the company announced.
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS ) is a good company. Cramer likes Brink's Company (NYSE: BCO ) and he would buy it at its current ...
The Zacks Analyst Blog Highlights: Cigna, EOG Resources, Northrop Grumman, Sherwin-Williams and Eaton
With less than two months to go, the consent decree was a big topic of conversation at a gathering of business leaders.
BioDelivery (BDSI) incurs narrower-than-expected loss in Q1. Sales surpass the consensus mark. The company raises guidance for 2019.
CNBC's Leslie Picker spoke on " Fast Money " about trading ideas revealed by notable investors on Ira Sohn conference. She said Jeff Gundlach is concerned about the budget deficit in the U.S. ...
Some of the best minds on Wall Street lent a peek into their portfolios at Monday’s Ira Sohn Investment Conference. Here are some of their recent plays. David Einhorn The Greenlight Capital founder is ...
Investors have it all wrong about the potential for Medicare for All to spell trouble for health insurers and hospital companies, according to Robbins.
Glenview Capital Management CEO Larry Robbins said at the Sohn Investment Conference on Monday that he’s shorting shares of industrial conglomerate 3M Co and is positive on healthcare stocks like Cigna Corp, Humana Inc and UnitedHealth Group Inc. Despite his long call on HMO equities, Robbins said he does not like pharmaceutical stocks due to the political risk, with many Democratic presidential hopefuls - as well as President Donald Trump - opposed to lofty drug prices.
Investing.com - Stocks recovered from sharp declines at the open to end the day with just small losses after China confirmed it had no plans to walk away from trade talks with the U.S. set for later this week, despite President Donald Trump threatening to hike tariffs on Beijing.